Indivior Pharmaceuticals Inc
INDV
Rang in aandelen
#3882
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Aandeelprijs
$34.01
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$4.24B
Verandering (1 dag)
4.81%
Verandering (1 jaar)
40.02%
Land
US
Handel Indivior Pharmaceuticals Inc (INDV)
Categorie
Healthcare
Winst voor Indivior Pharmaceuticals Inc (INDV)
Winst in Jun 2026 TTM: $393.00M
Volgens de meest recente financiële verslagen van Indivior Pharmaceuticals Inc bedraagt de huidige winst van het bedrijf $393.00M. In 2023 behaalde het bedrijf een winst van $-149.00M, een daling ten opzichte van de winst van 2022, die $-89.00M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Indivior Pharmaceuticals Inc van 2016 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $393.00M | 2,707.14% |
| 2024 | $14.00M | -109.40% |
| 2023 | $-149.00M | 67.42% |
| 2022 | $-89.00M | -146.84% |
| 2021 | $190.00M | -209.83% |
| 2020 | $-173.00M | -196.11% |
| 2019 | $180.00M | -32.21% |
| 2018 | $265.53M | 84.52% |
| 2017 | $143.91M | 60.35% |
| 2016 | $89.75M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 349.00% |
IN
|
